Rare cell-based liquid biopsy for improved measurement of low-grade chronic inflammation
Objectives and designLow-grade inflammation is a hallmark of chronic diseases. More sensitive tools for chronic low-grade inflammation detection are needed and herein presented as a proof of concept. Heightened sensitivity to inflammation may be achieved by analyzing the compensation mechanisms of h...
Saved in:
| Main Authors: | Stefan Schreier, Prapaphan Budchart, Suparerk Borwornpinyo, Panuwat Lertsithichai, Wannapong Triampo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Hematology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/frhem.2024.1472609/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rare Cell Population Analysis in Early-Stage Breast Cancer Patients
by: Stefan Schreier, et al.
Published: (2025-01-01) -
Opportunities and challenges of liquid biopsy in liver cancer
by: Yu-Chen Zhong, et al.
Published: (2023-12-01) -
Beyond tissue: Liquid biopsy's promise in unmasking oral cancer
by: Sakshi Deorah, et al.
Published: (2024-03-01) -
Liquid biopsy: paving a new avenue for cancer research
by: Keerthi Kurma, et al.
Published: (2024-12-01) -
Liquid biopsy in gallbladder carcinoma: Current evidence and future prospective
by: Sridhar Mishra, et al.
Published: (2024-12-01)